Analyst Recommendations

UBS analyst issues UNDERPERFORM recommendation for MRO on March 28, 2024 04:00PM ET. The previous analyst recommendation was Underperform.MRO was trading at $28.34 at issue of the analyst...

March 28, 2024   

UBS analyst issues UNDERPERFORM recommendation for MRO on March 28, 2024 04:00PM ET. The previous analyst recommendation was Underperform.MRO was trading at $28.34 at issue of the analyst...

March 28, 2024   

UBS analyst issues UNDERPERFORM recommendation for MRO on March 28, 2024 04:00PM ET. The previous analyst recommendation was Underperform.MRO was trading at $28.34 at issue of the analyst...

March 28, 2024   

UBS analyst issues UNDERPERFORM recommendation for MRO on March 28, 2024 04:00PM ET. The previous analyst recommendation was Underperform.MRO was trading at $28.34 at issue of the analyst...

March 28, 2024   

RBC Capital analyst issues UNDERPERFORM recommendation for DVN on March 28, 2024 03:00PM ET. The previous analyst recommendation was Underperform.DVN was trading at $50.215 at issue of the...

March 28, 2024   DVN -1.26%

Stifel Nicolaus analyst issues SECTOR PERFORM recommendation for DVN on March 28, 2024 03:00PM ET. The previous analyst recommendation was Sector Perform.DVN was trading at $50.215 at issue...

March 28, 2024   DVN -1.26%

Morgan Stanley analyst issues OVERWEIGHT recommendation for SU on March 28, 2024 09:15AM ET. The previous analyst recommendation was Overweight.SU was trading at $36.845 at issue of the...

March 28, 2024   SU 0.78%

Morgan Stanley analyst issues OVERWEIGHT recommendation for OXY on March 28, 2024 09:21AM ET. The previous analyst recommendation was Overweight.OXY was trading at $64.45 at issue of the...

March 28, 2024   OXY -1.15%

Morgan Stanley analyst issues OVERWEIGHT recommendation for DVN on March 28, 2024 09:17AM ET. The previous analyst recommendation was Overweight.DVN was trading at $49.85 at issue of the...

March 28, 2024   DVN -1.26%

Morgan Stanley analyst issues OVERWEIGHT recommendation for CVE on March 28, 2024 09:18AM ET. The previous analyst recommendation was Overweight.CVE was trading at $19.97 at issue of the...

March 28, 2024   CVE 2.49%